Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Effect of Excipients on Protein Formulation Viscosity

Published 09 October 2014 | By Malvern Panalytical

In the development of injectable biotherapeutics, drug efficacy and patient experience are both very important parameters. In order to maximize activity and efficacy, biotherapeutics are usually delivered intravenously or subcutaneously in high concentrations, typically >100g/mL, due to their short half-life in plasma.

Available Downloads

Effect of Excipients on Protein Formulation Viscosity